Michael S. Cuffe - Feb 18, 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and Chief Clinical Officer
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 18, 2022
Transactions value $: -$892,918
Form type: 4
Date filed: 2/23/2022, 06:14 PM
Previous filing: Feb 1, 2022
Next filing: Feb 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+10.8K	+60.35%	$0.00	28.8K	Feb 18, 2022	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$893K	-3.66K	-12.7%	$244.10	25.1K	Feb 18, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted.